World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
87
Citations
30660
World Ranking
2805
National Ranking
1445

Daria J. Hazuda publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Daria J. Hazuda sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 310 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Daria J. Hazuda D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Daria J. Hazuda sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 87 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Enzyme
  • DNA

Her main research concerns Virology, Integrase, Virus, Viral replication and Integrase inhibitor. She interconnects Acquired immunodeficiency syndrome and Immunology in the investigation of issues within Virology. Her Integrase study integrates concerns from other disciplines, such as Lentivirus and In vitro, Enzyme inhibitor, Enzyme.

Her work focuses on many connections between Viral replication and other disciplines, such as Molecular biology, that overlap with her field of interest in Jurkat cells and Kinase. The Integrase inhibitor study combines topics in areas such as Raltegravir Potassium and Raltegravir. Her Biochemistry research includes themes of Stereochemistry and Amyloid precursor protein.

Her most cited work include:

  • Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells (972 citations)
  • Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy (854 citations)
  • The challenge of finding a cure for HIV infection. (716 citations)

What are the main themes of her work throughout her whole career to date?

Her primary scientific interests are in Virology, Integrase, Stereochemistry, Enzyme and Virus. Her Virology research is multidisciplinary, incorporating perspectives in Reverse transcriptase and Immunology. Her Integrase research is multidisciplinary, relying on both Integrase inhibitor, In vitro, Viral replication and Lentivirus.

She usually deals with Integrase inhibitor and limits it to topics linked to Raltegravir and Raltegravir Potassium, Elvitegravir and Pharmacology. Her Enzyme study necessitates a more in-depth grasp of Biochemistry. Her biological study deals with issues like Mutant, which deal with fields such as Mutation.

She most often published in these fields:

  • Virology (34.11%)
  • Integrase (31.01%)
  • Stereochemistry (21.32%)

What were the highlights of her more recent work (between 2015-2021)?

  • Virology (34.11%)
  • Immune system (5.81%)
  • Immunology (8.53%)

In recent papers she was focusing on the following fields of study:

Her primary areas of study are Virology, Immune system, Immunology, In vivo and Virus. Her work in the fields of Virology, such as Viral replication and Hepatitis C virus, intersects with other areas such as Population. As a part of the same scientific study, Daria J. Hazuda usually deals with the Immunology, concentrating on Antiretroviral therapy and frequently concerns with Pegylated interferon, Pegylated interferon alpha-2b and Persistently infected.

Her In vivo course of study focuses on Cell and Histone deacetylase. Her research integrates issues of Asymptomatic and Mutant in her study of Virus. Her study looks at the relationship between Mutant and topics such as Nucleoside Reverse Transcriptase Inhibitor, which overlap with Molecular biology.

Between 2015 and 2021, her most popular works were:

  • Latency reversal and viral clearance to cure HIV-1 (152 citations)
  • PD-1 blockade potentiates HIV latency reversal ex vivo in CD4+ T cells from ART-suppressed individuals. (64 citations)
  • CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells. (63 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • DNA

Daria J. Hazuda mostly deals with Virology, Virus, Immune system, Immunology and Virus latency. Her Virology research is multidisciplinary, incorporating elements of Rilpivirine, Mutant and Dose–response relationship. Her research in Virus intersects with topics in Protein subunit, Epitope, Antigen, Immunogenicity and Vaccination.

Vorinostat, Cell killing and Provirus is closely connected to Viral protein in her research, which is encompassed under the umbrella topic of Immune system. Daria J. Hazuda frequently studies issues relating to Asymptomatic and Immunology. Daria J. Hazuda has researched Virus latency in several fields, including Cell, Ex vivo, Histone deacetylase, Panobinostat and T cell.

Best Publications

  • Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells

    Daria J. Hazuda;Peter Felock;Marc Witmer;Abigail Wolfe

  • HIV-1 Antiretroviral Drug Therapy

    Eric J. Arts;Daria J. Hazuda

  • The challenge of finding a cure for HIV infection.

    Douglas D. Richman;David M. Margolis;Martin Delaney;Warner C. Greene

  • Genome-Scale RNAi Screen for Host Factors Required for HIV Replication

    Honglin Zhou;Min Xu;Qian Huang;Adam T. Gates

  • Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

    Roy T. Steigbigel;David A. Cooper;Princy N. Kumar;Joseph E. Eron

  • Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection

    Vincenzo Summa;Alessia Petrocchi;Fabio Bonelli;Benedetta Crescenzi

  • P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro.

    Helena S.Y. Mancebo;Gary Lee;John Flygare;Joanne Tomassini

  • Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.

    David A. Cooper;Roy T. Steigbigel;Jose M. Gatell;Jurgen K. Rockstroh

  • Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes.

    Jay A. Grobler;Kara Stillmock;Binghua Hu;Marc Witmer

  • Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.

    Julian H. Elliott;Fiona Wightman;Ajantha Solomon;Khader Ghneim

  • Host Cell Factors in HIV Replication: Meta-Analysis of Genome-Wide Studies

    Frederic D. Bushman;Nirav Malani;Jason Fernandes;Jason Fernandes;Iván D'Orso;Iván D'Orso

  • HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase

    Amy S. Espeseth;Peter Felock;Abigail Wolfe;Marc Witmer

  • Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid

    Nancie M. Archin;Amy Espeseth;Daniel Parker;Manzoor Cheema

  • A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase.

    Daria J. Hazuda;Neville J. Anthony;Robert P. Gomez;Samson M. Jolly

  • Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro

    Giovanni Migliaccio;Joanne E. Tomassini;Steven S. Carroll;Licia Tomei

  • Integrase Inhibitors and Cellular Immunity Suppress Retroviral Replication in Rhesus Macaques

    Daria J. Hazuda;Steven D. Young;James P. Guare;Neville J. Anthony

  • Design and Synthesis of 8-Hydroxy-[1,6]Naphthyridines as Novel Inhibitors of HIV-1 Integrase in Vitro and in Infected Cells

    Linghang Zhuang;John S. Wai;Mark W. Embrey;Thorsten E. Fisher

  • 4-Aryl-2,4-dioxobutanoic acid inhibitors of HIV-1 integrase and viral replication in cells.

    John S. Wai;Melissa S. Egbertson;Linda S. Payne;Thorsten E. Fisher

  • Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds.

    J Tomassini;H Selnick;M E Davies;M E Armstrong

  • A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals

    Francesco Andrea Procopio;Rémi Fromentin;Deanna A. Kulpa;Jessica H. Brehm

Frequent Co-Authors

Michael D. Miller
Michael D. Miller United States Military Academy
Joseph P. Vacca
Joseph P. Vacca MSD (United States)
Sheo B. Singh
Sheo B. Singh MSD (United States)
Sander G. Mills
Sander G. Mills MSD (United States)
Malcolm Maccoss
Malcolm Maccoss MSD (United States)
Deborah L. Zink
Deborah L. Zink Weizenbaum-Institut
David B. Olsen
David B. Olsen MSD (United States)
Michael W. Miller
Michael W. Miller MSD (United States)
David M. Margolis
David M. Margolis University of North Carolina at Chapel Hill
Nicolas Chomont
Nicolas Chomont University of Montreal

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring studies in Biology or Biochemistry, a range of online degree options and career pathways are available in the US. Many students opt for accelerated programs, such as the bs in biology online, which allows for a flexible, fast-track approach to earning your credentials from anywhere.

Graduates interested in healthcare, nutrition, or laboratory sciences can expand their expertise through specialized programs. Consider advanced training with dietetic masters programs if you want to pursue nutrition or dietetics as a profession.

For those interested in direct patient care or clinical settings, there’s significant demand for allied health professionals. You can launch your career or upskill quickly with medical assistant programs online michigan, many of which offer financial aid options.

Already working as a medical assistant? Advance your career by bridging to nursing through an accessible ma to lpn bridge program online. This can open doors to a wider range of roles and greater earning potential.

Best Scientists Citing Daria J. Hazuda

Trending Scientists

Recently Published Articles